MYOS Issues Shareholder Letter Highlighting Key Accomplishments
13. Mai 2013 08:00 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - May 13, 2013) -  MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health nutritional supplements,...
MYOS Corporation Reports Fourth Quarter and Year End Financial Results for 2012
01. April 2013 08:00 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Apr 1, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health nutritional supplements,...
MYOS Clinical Research Study Confirms "Beneficial Effect" of MYO-T12 in Suppressing Myostatin Levels
20. März 2013 08:00 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Mar 20, 2013) -  MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health nutritional supplements,...
MYOS Corporation Appoints Glen R. Fleischer as Chief Executive Officer
03. Januar 2013 08:30 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Jan 3, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of products that improve human muscle health and...
MYOS Announces MYO-X Now Available in GNC; Vitamin Shoppe Soon to Follow
04. Dezember 2012 09:00 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Dec 4, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic products that improve muscle...
MYOS Appoints Sapna Srivastava as a Senior Advisor
12. November 2012 09:00 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Nov 12, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic products that improve muscle...
MYOS Appoints Andrew J. Einhorn as Chief Financial Officer
18. Oktober 2012 08:30 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Oct 18, 2012) -  MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic products that improve...
MYOS Files Patent for MYO-T12 to Prevent Muscle Loss
15. Oktober 2012 08:30 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Oct 15, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic products that improve muscle...
MYOS Announces That MYO-X Is Now Available Online at GNC.com
09. Oktober 2012 08:30 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Oct 9, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
MYOS Begins Groundbreaking Clinical Study on Muscle Health; Research Designed to Validate the Strengths of MYO-T12
20. September 2012 08:29 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Sep 20, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...